If Metformin Inhibited the Mitochondrial Glycerol Phosphate Dehydrogenase It Might Not Benefit Diabetes
MacDonald, M. J.; Ansari, I.-u. H.; Longacre, M. J.; Stoker, S. W.
Show abstract
The mitochondrial glycerol phosphate dehydrogenase is the rate-limiting enzyme of the glycerol phosphate shuttle. It was recently claimed that metformin, a first line drug used worldwide for the treatment of type 2 diabetes, works by inhibiting the mitochondrial glycerol phosphate dehydrogenase 30-50% thus suppressing hepatic gluconeogenesis. This enzyme is 30-60 fold higher in the pancreatic islet than in liver. If metformin actually inhibited the enzyme, why would it not inhibit insulin secretion and exacerbate diabetes? Total body knockout of the mitochondrial glycerol phosphate dehydrogenase does not inhibit insulin secretion because insulin cells and liver cells possess the malate aspartate shuttle that is redundant to the action of the glycerol phosphate shuttle. In view of these and other apparent inconsistencies we reassessed the idea that metformin inhibited the mitochondrial glycerol phosphate dehydrogenase. We measured the enzymes activity in whole cell homogenates and mitochondria of insulin cells and liver cells using four different enzyme assays and were unable to show that metformin directly inhibits the enzyme. We conclude that metformin does not actually inhibit the enzyme. If it did, it might not be efficacious as a diabetes medicine.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Metformin Is Associated with Favorable Outcomes in Patients with COVID-19 and Type 2 Diabetes Mellitus 92%
- Gene and metabolite expression dependence on body mass index in human myocardium 91%
- Identification of metabolomics biomarkers for type 2 diabetes: triangulating evidence from longitudinal and Mendelian randomization analyses 90%
Similar papers in this journal
- Non-autoimmune, lean diabetes in young people from Assam, India highlights the role of undernutrition in its aetiology - PHEnotypingNOrthEastINDianYoung type 2 diabetes (PHENOEINDY-2) 91%
- Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver 91%
- Role of Weight Loss Induced Prediabetes Remission in the Prevention of Type 2 Diabetes – Time to Improve Diabetes Prevention 90%
Similar papers in this journal
- Cocoa extract exerts sex-specific anti-diabetic effects in an aggressive type-2 diabetes model: a pilot study 91%
- Mitochondrial diabetes in mice expressing a dominant-negative allele of nuclear respiratory factor-1 (NRF1) in pancreatic and β-cells 89%
- A Novel No-Wash (Homogenous) High-Throughput Toxicity Assay on Primary Cells 89%
Similar papers in this journal
- Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats 91%
- Relationship between serum bilirubin levels, urinary biopyrrin levels, and retinopathy in patients with diabetes 91%
- Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.